ACCENDRA HEALTH INC (ACH) Stock Price, Forecast & Analysis

NYSE:ACH • US6907321029

2.37 USD
-0.01 (-0.42%)
Last: Feb 12, 2026, 11:11 AM

ACH Key Statistics, Chart & Performance

Key Statistics
Market Cap183.32M
Revenue(TTM)6.71B
Net Income(TTM)-1.34B
Shares77.35M
Float74.52M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)1.29
PE1.84
Fwd PE2.5
Earnings (Next)02-19
IPO1980-03-17
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Distributors
ACH short term performance overview.The bars show the price performance of ACH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10

ACH long term performance overview.The bars show the price performance of ACH in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ACH is 2.37 USD. In the past month the price decreased by -5.18%.

ACCENDRA HEALTH INC / ACH Daily stock chart

ACH Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ACH.


Chartmill TA Rating
Chartmill Setup Rating
ACH Full Technical Analysis Report

ACH Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ACH. ACH has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ACH Full Fundamental Analysis Report

ACH Financial Highlights

Over the last trailing twelve months ACH reported a non-GAAP Earnings per Share(EPS) of 1.29. The EPS decreased by -22.29% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -33.21%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-40.48%
Sales Q2Q%-74.37%
EPS 1Y (TTM)-22.29%
Revenue 1Y (TTM)-37.09%
ACH financials

ACH Forecast & Estimates

12 analysts have analysed ACH and the average price target is 3.77 USD. This implies a price increase of 59.24% is expected in the next year compared to the current price of 2.37.

For the next year, analysts expect an EPS growth of -31.69% and a revenue growth -74.09% for ACH


Analysts
Analysts50
Price Target3.77 (59.07%)
EPS Next Y-31.69%
Revenue Next Year-74.09%
ACH Analyst EstimatesACH Analyst Ratings

ACH Ownership

Ownership
Inst Owners97.53%
Ins Owners3.39%
Short Float %12.45%
Short Ratio4.2
ACH Ownership

About ACH

Company Profile

ACH logo image Accendra Health, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. The company is headquartered in Glen Allen, Virginia and currently employs 13,500 full-time employees. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. The company offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.

Company Info

ACCENDRA HEALTH INC

10900 Nuckols Road, Suite 400

Glen Allen VIRGINIA 100082 US

CEO: Lu Dongliang

Employees: 13500

ACH Company Website

ACH Investor Relations

Phone: 18042774304

ACCENDRA HEALTH INC / ACH FAQ

What does ACH do?

Accendra Health, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. The company is headquartered in Glen Allen, Virginia and currently employs 13,500 full-time employees. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. The company offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.


Can you provide the latest stock price for ACCENDRA HEALTH INC?

The current stock price of ACH is 2.37 USD. The price decreased by -0.42% in the last trading session.


Does ACH stock pay dividends?

ACH does not pay a dividend.


How is the ChartMill rating for ACCENDRA HEALTH INC?

ACH has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Would investing in ACCENDRA HEALTH INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ACH.


What is the employee count for ACH stock?

ACCENDRA HEALTH INC (ACH) currently has 13500 employees.


When does ACCENDRA HEALTH INC (ACH) report earnings?

ACCENDRA HEALTH INC (ACH) will report earnings on 2026-02-19, after the market close.